Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year.
ACOR Opens Cancer-pain.org
Connie Mack Joins Washington Office Of Shaw Pittman.
Richard Wood, ICRF, Accepts Appointment At Pittsburgh.
Cancer Groups In Campaign To Draft Pazdur For FDA.
NCI Seeks 150 Advocates For Advice On Plans, Policies.
“Harm-Reduction” Products No Proven, IOM Report Says.
MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.
FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.
Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.
Response Oncology Sells Practice Back To Physicians.
EntreMed Issued U.S. Patent For Active Parts Of Endostatin.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
